Institutional Investors Have a Lot Riding on APT Medical Inc. (SHSE:688617) With 37% Ownership
Institutional Investors Have a Lot Riding on APT Medical Inc. (SHSE:688617) With 37% Ownership
Key Insights
关键见解
- Significantly high institutional ownership implies APT Medical's stock price is sensitive to their trading actions
- A total of 5 investors have a majority stake in the company with 51% ownership
- Insiders own 36% of APT Medical
- 高机构所有权意味着APT Medical的股价对其交易行为很敏感
- 共有5名投资者持有该公司的多数股权,所有权为51%
- 业内人士拥有APT Medical36%的股份
To get a sense of who is truly in control of APT Medical Inc. (SHSE:688617), it is important to understand the ownership structure of the business. With 37% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).
要了解谁真正控制了APT Medical Inc.(上海证券交易所代码:688617),了解该业务的所有权结构非常重要。机构拥有37%的股份,是公司的最大股份。换句话说,该集团面临最大的上行潜力(或下行风险)。
Last week's 7.0% gain means that institutional investors were on the positive end of the spectrum even as the company has shown strong longer-term trends. One-year return to shareholders is currently 26% and last week's gain was the icing on the cake.
上周7.0%的涨幅意味着,尽管该公司表现出强劲的长期趋势,但机构投资者仍处于积极的一端。目前,一年股东回报率为26%,上周的涨幅锦上添花。
Let's delve deeper into each type of owner of APT Medical, beginning with the chart below.
让我们从下图开始,深入研究APT Medical的每种类型的所有者。
![ownership-breakdown](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240213/0-11fff4071c515afe0c6379d3cfa2352e-0-5cc03f8678e58036e8c2d5330841b7a2.png/big)
What Does The Institutional Ownership Tell Us About APT Medical?
关于APT Medical,机构所有权告诉我们什么?
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
机构投资者通常将自己的回报与常见指数的回报进行比较。因此,他们通常会考虑收购相关基准指数中包含的大型公司。
We can see that APT Medical does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at APT Medical's earnings history below. Of course, the future is what really matters.
我们可以看到,APT Medical确实有机构投资者;他们持有该公司很大一部分股票。这意味着在这些机构工作的分析师已经看过这只股票,他们很喜欢。但是就像其他人一样,他们可能错了。如果多家机构同时改变对股票的看法,你可能会看到股价快速下跌。因此,值得在下面查看APT Medical的收益记录。当然,未来才是真正重要的。
![earnings-and-revenue-growth](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240213/0-11fff4071c515afe0c6379d3cfa2352e-1-ac2cb502cef65c309dda8219fb62e23b.png/big)
APT Medical is not owned by hedge funds. The company's CEO Zhenghui Cheng is the largest shareholder with 33% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 6.2% and 4.6%, of the shares outstanding, respectively.
APT Medical不归对冲基金所有。该公司首席执行官程正辉是最大股东,已发行股份的33%。同时,第二和第三大股东分别持有已发行股份的6.2%和4.6%。
To make our study more interesting, we found that the top 5 shareholders control more than half of the company which implies that this group has considerable sway over the company's decision-making.
为了使我们的研究更有趣,我们发现前五名股东控制着公司一半以上的股份,这意味着该集团对公司的决策具有相当大的影响力。
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.
虽然研究公司的机构所有权数据是有意义的,但研究分析师的情绪以了解风向哪个方向吹来也是有意义的。有相当数量的分析师在报道该股,因此了解他们对未来的总体看法可能很有用。
Insider Ownership Of APT Medical
APT Medical 的内部所有权
The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.
公司内部人员的定义可能是主观的,并且在不同的司法管辖区之间确实有所不同。我们的数据反映了个人内部人士,至少涵盖了董事会成员。管理层最终对董事会负责。但是,经理成为执行委员会成员的情况并不少见,尤其是当他们是创始人或首席执行官时。
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
当内部所有权表明领导层像公司的真正所有者一样思考时,内部所有权是积极的。但是,高度的内部所有权也可以赋予公司内部的一小部分人巨大的权力。在某些情况下,这可能是负面的。
Our information suggests that insiders maintain a significant holding in APT Medical Inc.. Insiders own CN¥11b worth of shares in the CN¥30b company. That's quite meaningful. Most would say this shows a good degree of alignment with shareholders, especially in a company of this size. You can click here to see if those insiders have been buying or selling.
我们的信息表明,内部人士持有APT Medical Inc.的大量股份。内部人士拥有这家300亿元人民币公司价值110亿元人民币的股份。这很有意义。大多数人会说,这表明了与股东的良好一致性,尤其是在如此规模的公司中。你可以点击这里查看这些内部人士是否在买入或卖出。
General Public Ownership
一般公有制
The general public, who are usually individual investors, hold a 15% stake in APT Medical. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
公众通常是个人投资者,持有APT Medical15%的股份。这种所有权规模虽然可观,但如果决策与其他大股东不同步,可能不足以改变公司政策。
Private Company Ownership
私人公司所有权
Our data indicates that Private Companies hold 12%, of the company's shares. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.
我们的数据表明,私营公司持有公司12%的股份。私人公司可能是关联方。有时,内部人士通过控股私营公司而不是以个人身份对上市公司感兴趣。虽然很难得出任何广泛的中风结论,但值得注意的是,这是一个需要进一步研究的领域。
Next Steps:
后续步骤:
While it is well worth considering the different groups that own a company, there are other factors that are even more important.
虽然值得考虑拥有公司的不同群体,但还有其他更为重要的因素。
I like to dive deeper into how a company has performed in the past. You can access this interactive graph of past earnings, revenue and cash flow, for free.
我喜欢更深入地了解一家公司过去的表现。您可以免费访问这张过去的收益、收入和现金流的交互式图表。
If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
如果你像我一样,你可能需要考虑这家公司是会成长还是会萎缩。幸运的是,您可以查看这份免费报告,其中显示了分析师对其未来的预测。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注意:本文中的数字是使用过去十二个月的数据计算得出的,这些数据是指截至财务报表日期当月最后一天的12个月期间。这可能与全年年度报告数据不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。